Expert Interview
Reviewing the clinical landscape of Cerebral Adrenoleukodystrophy with a focused look at Bluebird's newly approved therapy, Skysona
Ticker(s): BLUEInstitution: Mount Sinai
- Assistant Professor of Genetics and Genomic Science & co-director of the Mitochondrial Medicine Program in the Division of Medical Genetics at Mount Sinai.
- Manages 3 patients with CALD and has treated ~15 in his career.
- Special interests are inborn errors of metabolism, newborn screening, and mitochondrial disorders; runs clinics to diagnose and treat patients with inborn errors of metabolism.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
